Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03650140 · ClinicalTrials.gov registry record · NA
Pharmacokinetics and Pharmacodynamics of Anthocyanins
A NA study of Gout, sponsored by Rutgers, The State University of New Jersey.
- Completed
- Registry status
- NA
- Development phase
- 10
- Enrollment target
- 1
- Study location
NCT03650140: Completed NA study of Gout, sponsored by Rutgers, The State University of New Jersey.
NCT03650140 is a NA study of Gout that has completed, run by Rutgers, The State University of New Jersey. The registered enrollment target is 10 participants, below the 8,888-participant average among 34 other Gout trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03650140, a NA study of Gout, has completed, sponsored by Rutgers, The State University of New Jersey.
- COMPLETED
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of the study is to establish the pharmacokinetic parameters of cherry juice concentrate and identify its potential to alter inflammatory markers in gout patients.
Primary Outcome
Reduction in hs-CRP
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Tart cherry extract 60 mL
- DIETARY_SUPPLEMENT Tart cherry extract 120 mL
Study Locations (1)
New Jersey
- Robert Wood Johnson Medical School - New Brunswick
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2019-02-01 |
| Est. Completion | 2022-06-06 |
| Phase | NA |
What the finished NCT03650140 record still lists
NCT03650140 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 8,888-participant average among 34 other Gout trials with a reported enrollment target (100% lower).
The record links to 1 condition, with Gout appearing as the primary indexed condition, and to 2 interventions - of which Tart cherry extract 60 mL is the first listed.
NCT03650140 reports a single indexed study location in New Jersey.
Frequently Asked Questions
What is clinical trial NCT03650140 about?
NCT03650140 is a clinical study titled "Pharmacokinetics and Pharmacodynamics of Anthocyanins". The purpose of the study is to establish the pharmacokinetic parameters of cherry juice concentrate and identify its potential to alter inflammatory markers in gout patients.
What is the current status of trial NCT03650140?
This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2019-02-01. Estimated completion is 2022-06-06.
What conditions does trial NCT03650140 study?
This clinical trial studies the following conditions: Gout.
What interventions are being tested in trial NCT03650140?
The interventions under investigation include: Tart cherry extract 60 mL (DIETARY_SUPPLEMENT), Tart cherry extract 120 mL (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT03650140?
This trial is sponsored by Rutgers, The State University of New Jersey, which has 413 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03650140 being conducted?
This trial has 1 study location across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Gout
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03650140's enrollment target sits among peer trials
10 33rd of 34 higher than 2 of 34 other Gout trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Gout trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Dose Response of Exercise for Arthritis Management
RECRUITING · NA
-
Improving Gout Care After an ED Visit
RECRUITING · NA
-
Gout in the ED and Improving Research Participation
ACTIVE NOT RECRUITING · NA
-
Novel Methods for Ascertainment of Gout Flares -A Pilot Study
COMPLETED · NA
-
The Diet Gout Trial
COMPLETED · NA
-
UR+AIMS Gout Wearable Skin Uric Acid Monitor Study
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI